Clinical Guide: Pulmonary Sequestration (Bronchopulmonary Sequestration)

1. Comprehensive Introduction & Overview

Pulmonary sequestration (PS) is a rare congenital bronchopulmonary malformation characterized by a non-functioning mass of pulmonary tissue that lacks normal communication with the tracheobronchial tree. Crucially, this sequestered tissue receives its blood supply from the systemic circulation, rather than the pulmonary arterial circulation.

While historically considered a rare anomaly, the increasing utilization of high-resolution cross-sectional imaging (CT and MRI) has led to more frequent incidental detection in both pediatric and adult populations. Understanding the distinction between the two primary types—Intralobar Sequestration (ILS) and Extralobar Sequestration (ELS)—is the cornerstone of clinical management.

2. Deep-Dive: Pathophysiology and Etiology

The Embryological Basis

Pulmonary sequestration arises from the abnormal development of the primitive foregut. During the embryonic period, an accessory lung bud may emerge from the ventral aspect of the foregut. If this bud migrates caudally, it retains its systemic blood supply—a vestige of the dorsal aorta—rather than undergoing the normal transition to pulmonary circulation.

Mechanism of Sequestration

• Intralobar Sequestration (ILS): The sequestered tissue is embedded within the normal lung parenchyma, sharing the same visceral pleura. Because it lacks a connection to the bronchial tree, it cannot clear secretions, making it a "nidus" for recurrent infections.
• Extralobar Sequestration (ELS): This is a completely separate anatomic structure, often located in the posterior costodiaphragmatic recess. Because it is encapsulated by its own pleura, it rarely communicates with the bronchial tree and is less prone to infection than ILS, often presenting as a mass effect.

Hemodynamics

The systemic arterial supply usually originates from the thoracic or abdominal aorta. This high-pressure input into a low-resistance pulmonary vascular bed can theoretically lead to left-to-left shunting, although this is rarely hemodynamically significant unless the sequestration is massive.

3. Clinical Indications & Standard Presentation

The clinical presentation of pulmonary sequestration is highly dependent on the type and the presence of superimposed infection.

Clinical Presentation by Subtype

• ILS Symptoms: Typically presents in late childhood or early adulthood. Patients often describe a history of recurrent pneumonia, chronic cough, hemoptysis, or localized pleuritic chest pain.
• ELS Symptoms: Often asymptomatic and discovered incidentally on prenatal ultrasound or neonatal chest X-rays. If symptomatic, it is usually due to mass effect (e.g., respiratory distress in neonates due to compression of the healthy lung).

Diagnostic Pathway

1. Chest Radiograph (CXR): Often shows a non-specific opacity, a cystic lesion, or a triangular density at the lung base.
2. Computed Tomography Angiography (CTA): The "Gold Standard." CTA is mandatory to visualize the aberrant systemic artery feeding the mass.
3. Magnetic Resonance Angiography (MRA): Preferred in pediatric patients to avoid ionizing radiation, providing excellent resolution of vascular anatomy.
4. Doppler Ultrasound: Highly effective in prenatal diagnosis to identify the feeding vessel.

4. Differential Diagnosis

Distinguishing pulmonary sequestration from other thoracic pathologies is critical to avoid catastrophic hemorrhage during surgical intervention.

• Congenital Pulmonary Airway Malformation (CPAM): Often involves systemic supply but usually communicates with the airway.
• Pulmonary Arteriovenous Malformation (AVM): Characterized by direct communication between pulmonary arteries and veins.
• Infected Lung Abscess: Can mimic the appearance of ILS; however, the lack of a systemic feeder differentiates the two.
• Bronchogenic Cyst: Usually mediastinal, not intrapulmonary, and lacks systemic arterial supply.
• Diaphragmatic Hernia: Must be considered for any left-sided basal mass in a neonate.

5. Risks, Contraindications, and Surgical Management

Surgical Intervention

Surgical resection is the definitive treatment for symptomatic sequestration.

Critical Warning: The most significant surgical risk is catastrophic intraoperative hemorrhage. Because the systemic artery can be large and fragile, failure to identify and ligate the systemic feeder before manipulating the lung tissue can lead to life-threatening bleeding.

• Standard Procedure: Lobectomy or segmentectomy for ILS; excision of the sequestration for ELS.
• Minimally Invasive Approaches: VATS (Video-Assisted Thoracoscopic Surgery) is now the preferred approach for experienced centers, reducing recovery time and morbidity.
• Embolization: In cases where surgery is high-risk (e.g., severe comorbidities), percutaneous transcatheter embolization of the feeding artery may be utilized as a palliative or temporizing measure.

Contraindications to Surgery

• Asymptomatic ELS detected in adulthood (often managed with observation).
• Severe cardiopulmonary instability that precludes anesthesia.
• Extensive bilateral disease where resection would result in respiratory insufficiency.

6. Long-Term Prognosis

The prognosis for patients with pulmonary sequestration is excellent following surgical resection.

• Post-Operative Recovery: Most patients regain normal lung function. In ILS cases, the surrounding lung tissue often re-expands and compensates for the removed segment.
• Recurrence: Extremely rare if the sequestration is completely excised.
• Monitoring: Long-term follow-up is generally not required for asymptomatic patients who have undergone successful resection, though baseline pulmonary function testing is recommended for pediatric patients to ensure appropriate lung growth.

7. Frequently Asked Questions (FAQ)

1. Is pulmonary sequestration a form of cancer?
No. It is a congenital developmental anomaly. It is not malignant.

2. Can pulmonary sequestration resolve on its own?
While some prenatal cases may show regression in size during fetal development, the structure itself does not disappear. Surgical intervention is usually required for symptomatic postnatal cases.

3. Why is a CT angiogram necessary?
A standard CT scan shows the mass, but a CT Angiogram (CTA) is essential to map the aberrant systemic arteries. Surgeons must know the location of these vessels to prevent massive bleeding during surgery.

4. Can an adult be diagnosed with pulmonary sequestration?
Yes. Many cases of Intralobar Sequestration remain undiagnosed until adulthood when they present as recurrent pneumonia.

5. What is the difference between ILS and ELS?
ILS is integrated into the lung tissue and shares the pleura; ELS is a distinct mass with its own pleura, often located outside the lung.

6. Is surgery always required?
No. Asymptomatic ELS or ILS discovered incidentally in adults may be managed with careful observation. However, symptomatic cases require resection.

7. Is there a genetic component to this condition?
Pulmonary sequestration is generally considered a sporadic developmental error. It is not typically inherited in a Mendelian fashion.

8. What are the symptoms of an infected sequestration?
Fever, productive cough, purulent sputum, and localized chest pain. It mimics bacterial pneumonia.

9. Can embolization replace surgery?
Embolization is typically reserved for high-risk surgical candidates. It can shrink the sequestration by cutting off its blood supply, but surgical removal remains the gold standard.

10. Does pulmonary sequestration affect life expectancy?
With proper management and surgical treatment, patients have a normal life expectancy.

8. Clinical Summary for Specialists

Pulmonary sequestration represents a unique intersection of embryology and clinical thoracic surgery. The primary clinical imperative is the preoperative identification of the systemic arterial supply. Failure to recognize this vascular anomaly is the primary cause of surgical complications.

Clinicians should maintain a high index of suspicion for sequestration in any patient presenting with recurrent lower lobe infections or a persistent basal opacity on imaging. Through the use of modern CTA and minimally invasive surgical techniques, the morbidity associated with this condition has been significantly reduced, ensuring excellent long-term outcomes for the vast majority of patients.

Disclaimer: This document is for educational and informational purposes for medical professionals. It does not replace clinical judgment, institutional protocols, or direct consultation with thoracic surgical specialists. Always perform a thorough vascular assessment prior to any surgical intervention involving pulmonary masses.